ArticleBMC infectious diseases2025
Pasteurella multocida infection: a differential retrospective study of 482 cases of P. multocida infection in patient of different ages.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- Peritoneal Dialysis-Associated Peritonitis due toInfectious diseases & clinical microbiology · 2026Article
- Study on the Pathogenic Mechanism ofPathogens (Basel, Switzerland) · 2026Review
- Article
- Pathogens Associated with Domestic Cats (Pathogens (Basel, Switzerland) · 2026Review
- Antimicrobial Susceptibility of HumanInfection & chemotherapy · 2026Article
- Article
- Clinical, Pathological, and Antimicrobial Characteristics ofVeterinary sciences · 2026Article
- Outer Membrane Vesicles Derived from Yak Isolates ofAnimals : an open access journal from MDPI · 2026Article
- Comparative pangenomics of Pasteurella multocida uncovers adhesins specific to capsular serogroup B strains associated with bovine host tropism.BMC microbiology · 2026Article
- Article
- Isolation and identification of Pasteurella species and other bacterial organisms from ovine pneumonic lungs and their antimicrobial susceptibility in Ghana: abattoir-based study.Frontiers in veterinary science · 2026Article
- Management Strategies forAesthetic surgery journal. Open forum · 2026Article
- Mechanism of GSDMD in the Pathogenesis ofTransboundary and emerging diseases · 2026Article
- AggressiveIDCases · 2026Article
- Pasteurella multocida Bacteremia in a Young Infant.Cureus · 2025Article
- Comprehensive capsular, lipopolysaccharide, virulence, and antimicrobial resistance profiling ofVeterinary world · 2025Article
- Article
- Phenotypical and genotypical resistance testing ofFrontiers in veterinary science · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThere is limited data regarding the sources of human Pasteurella multocida infection, characteristics of infected populations, and the antibiotic resistance patterns of human strains.
methodsThrough the multi-database platforms, we conducted a comprehensive review and analysis of 482 reported cases of Pasteurella multocida from the world since from 1964 to 2023, including the sources of infection, sex and age distribution of infected individuals, and the clinical manifestations of infection in different age groups. Additionally, we evaluated the antibiotic susceptibility of different strains of the bacterium.
resultsP. multocida infection is mainly involved in infants and the elderly population, and it is closely related to animal exposure (cats 54.1%, dogs 29%), especially cat-related infections in adults and older are significantly more common than in children (P = 0.005, P < 0.001). Infection with P. multocida can cause local redness of the skin and soft tissue (11.6%), and also progress to systemic infection, like central nervous system (14.5%), especially in children, Cardiovascular system (29.3%), respiratory system (21.4%), digestive system (12.9%), urogenital system (2.9%) and bone and joint infections (5%). In terms of treatment, first-line treatment is priority to with penicillin. However there are also resistance to Penicillins and β-lactam antibiotics (18 cases were reported), and strains derived from wounds, blood and respiratory tract are resistant to multiple antibiotics.
conclusionP. multocida primarily causes infections through cats and dogs in different age groups, leading to various clinical manifestations and outcomes. It is generally sensitive to penicillin antibiotics but exhibits varying resistance among strains of different clinical origins. Studying these aspects is crucial to raise awareness about preventing P. multocida infections and to standardize clinical treatment approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.